Craig Venter launches Human Longevity, Inc. to combat age-related diseases

Yesterday, March 4th, Craig Venter and entrepreneur colleagues announced the launch of their new company, Human Longevity, Inc. (HLI). The company plans to sequence massive numbers of full human genomes, as well as the DNA of human-associated microbes and pathogens, to discover the bases of aging and degenerative diseases. HLI's goal is to sequence 40,000 human genomes in the first year and the first disease to be targeted is cancer. This announcement was featured in many popular new sources, including The New York Times.